The Comparative Efficacy of an Over the Counter Light Therapy Mask vs Over the Counter Topical Benzoyl Peroxide 2.5% and Used in Combination With Over the Counter Adapalene Gel 0.1% for Mild to Moderate Acne
NCT ID: NCT03650881
Last Updated: 2020-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2018-08-07
2020-02-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne.
NCT02698436
Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications
NCT00926367
A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne
NCT03124381
Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris
NCT00558831
Study of Two Different 10.0% Benzoyl Peroxide Creams for Mild to Moderate Acne Vulgaris
NCT00787943
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Neutrogena ® Light Therapy Acne Mask (MASK)
Over-the-counter powered light-based device for the treatment of acne
Neutrogena ® Light Therapy Acne Mask (MASK)
Daily use of the OTC Neutrogena Light Therapy Acne Mask once daily for 10 minutes
Topical benzoyl peroxide 2.5% gel and OTC adapalene
Over-the-counter medication for the treatment of acne + 0.1% Adepalene Gel
Topical OTC benzoyl peroxide 2.5% gel and OTC adapalene
Daily treatment with Reference Therapy OTC topical generic benzoyl peroxide 2.5% gel in the morning and OTC generic adapalene 0.1% gel at night
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neutrogena ® Light Therapy Acne Mask (MASK)
Daily use of the OTC Neutrogena Light Therapy Acne Mask once daily for 10 minutes
Topical OTC benzoyl peroxide 2.5% gel and OTC adapalene
Daily treatment with Reference Therapy OTC topical generic benzoyl peroxide 2.5% gel in the morning and OTC generic adapalene 0.1% gel at night
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mild-to-moderate acne defined as a grade 2 or 3 on the FDA Investigator Global Acne Assessment (IGA) for Acne vulgaris (Appendix 1)19
* If female,
* Negative urine pregnancy test at the time of enrollment and negative urine pregnancy tests at follow up visits
* Agreement to comply with medically acceptable forms of birth control with heterosexual intercourse
* Agreement to comply with the study protocol and attend all study visits
Exclusion Criteria
* Outside of specified age range
* Patients with clear, almost clear acne, or severe acne defined as grade 0-1 or 4 on the IGA Scale
* Females who are pregnant or breastfeeding
* Known allergy to any ingredients in the test products or history of photosensitivity
* Pre-existing facial dermatologic conditions including excoriations that could interfere with the outcome of this study and quantification of acne lesions
* Excessive facial hair or scarring that could interfere with quantification of acne lesions
* Does not have decision making capacity
12 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-01725
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.